U.S. Corporations Face Reckoning Over Prescription Opioids, CEOs Keep Cashing In

Steve Collis, president and chief executive officer of AmerisourceBergen Corp., testifies during a House Energy and Commerce Subcommittee hearing on May 8, 2018.

Companies that sold or distributed opioid medications face huge legal, financial and public relations peril. Critics say shareholders, not CEOs, will pay the price.

(Image credit: Bloomberg/Getty Images)



from News : NPR https://ift.tt/3w6hIpT

No comments

Powered by Blogger.